Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: A randomized controlled study

References

• Heath RB. Prevention of varicella by vaccination. J Hosp Infect 1988; 11 Suppl A:90-5; PMID:2896753.
   PubMed Web of Science ®Google Scholar
• Chiu SS, Lau YL. Review of the Varilrix varicella vaccine. Expert Rev Vaccines 2005; 4:629-43; PMID:16221065
   PubMed Web of Science ®Google Scholar
• Iseli A, Aebi C, Banz K, Brunner M, Schmutz AM, Heininger U. Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland. Hum Vaccin 2009; 5:843-6; PMID:19829056
   PubMed Web of Science ®Google Scholar
• Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health 1998; 3:886-90; PMID:9855401
   PubMed Web of Science ®Google Scholar
• Yawn BP, Yawn RA, Lydick E. Community impact of childhood varicella infections. J Pediatr 1997; 130:759-65; PMID:9152286
   PubMed Web of Science ®Google Scholar
• Losurdo G, Bertoluzzo L, Canale F, Timitilli A, Bondi E, Castagnola E, Giacchino R. Varicella and its complications as cause of hospitalization. Infez Med 2005; 13:229-34; PMID:16388278
   PubMedGoogle Scholar
• Lieu TA, Black SB, Rieser N, Ray P, Lewis EM, Shinefield HR. The cost of childhood chickenpox: parents' perspective. Pediatr Infect Dis J 1994; 13:173-7; PMID:8177622
   PubMed Web of Science ®Google Scholar
• Sullivan-Bolyai JZ, Yin EK, Cox P, Marchand A, Meissinger J, Venerable L, Weiss B. Impact of chickenpox on households of healthy children. Pediatr Infect Dis J 1987; 6:33-5; PMID:3822615
   PubMed Web of Science ®Google Scholar
• Balraj V, John TJ. An epidemic of varicella in rural southern India. J Trop Med Hyg 1994; 97:113-6; PMID:8170001
   PubMedGoogle Scholar
• Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, Bock HL, Kanwal S, Shah RC, Shah N. Age related seroprevalence of antibodies to varicella in India. Indian Pediatr 2000; 37:714-9; PMID:10906803
   PubMedGoogle Scholar
• Verma R, Bairwa M, Chawla S, Prinja S, Rajput M. Should the chickenpox vaccine be included in the National Immunization Schedule in India? Hum Vaccin 2011; 7:874-7; PMID:21791972
   PubMed Web of Science ®Google Scholar
• Krause PR, Klinman DM. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J Pediatr 1995; 127:518-25; PMID:7562270
   PubMed Web of Science ®Google Scholar
• WHO: Vaccine Position Papers,Weekly Epidemiological Record. Available from: http://www.who.int/immunization/wer7332varicella_Aug98_position_paper.pdf?ua=1 . Accessed March 12 2014 1998
   Google Scholar
• Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 2004; 23:132-7; PMID:14872179
   PubMed Web of Science ®Google Scholar
• Lau YL, Vessey SJ, Chan IS, Lee TL, Huang LM, Lee CY, Lin TY, Lee BW, Kwan K, Kasim SM, et al. A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children. Vaccine 2002; 20:2942-9; PMID:12126906
   PubMed Web of Science ®Google Scholar
• Tan AY, Connett CJ, Connett GJ, Quek SC, Yap HK, Meurice F, Lee BW. Use of a reformulated Oka strain varicella vaccine (SmithKline Beecham Biologicals/Oka) in healthy children. Eur J Pediatr 1996; 155:706-11; PMID:8839730
   PubMed Web of Science ®Google Scholar
• Varicella Vaccine (live), Freeze-dried. Available from: http://www.cs-vaccine.com/en/cp_page.asp?id=329.Accessed on September27,2014
   Google Scholar
• Michalik DE, Steinberg SP, Larussa PS, Edwards KM, Wright PF, Arvin AM, Gans HA, Gershon AA. Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis 2008; 197:944-9; PMID:18419532
   PubMed Web of Science ®Google Scholar
• Li S, Chan IS, Matthews H, Heyse JF, Chan CY, Kuter BJ, Kaplan KM, Vessey SJ, Sadoff JC. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long-term breakthrough infection. Pediatr Infect Dis J 2002; 21:337-42; PMID:12075766
   PubMed Web of Science ®Google Scholar
• Kosuwon P, Sutra S, Kosalaraksa P. Advantage of a two-dose vs. one-dose varicella vaccine in healthy non-immune teenagers and young adults. Southeast Asian J Trop Med Public Health 2004; 35:697-701; PMID:15689090
   PubMedGoogle Scholar
• Kuter BJ, Weibel RE, Guess HA, Matthews H, Morton DH, Neff BJ, Provost PJ, Watson BA, Starr SE, Plotkin SA. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine. 1991; 9:643-7; PMID:1659052
   PubMed Web of Science ®Google Scholar
• Ramkissoon A, Coovadia HM, Jugnundan P, Haffejee IE, Meurice F, Vandevoorde D. Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months. S Afr Med J 1995; 85:1295-8; PMID:8600589
   PubMed Web of Science ®Google Scholar
• Diaz-Mitoma F, Halperin SA, Scheifele D. Reactogenicity to a live attenuated varicella vaccine in Canadian children. Can J Infect Dis 2000; 11:97-101; PMID:18159273
   PubMedGoogle Scholar
• Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics 1986; 78:748-56; PMID:3020494
   PubMed Web of Science ®Google Scholar
• Gershon AA, LaRussa P, Hardy I, Steinberg S, Silverstein S. Varicella vaccine: the American experience. J Infect Dis 1992; 166 Suppl 1:S63-8; PMID:1320652
   PubMedGoogle Scholar
• Plotkin SA, Starr SE, Connor K, Morton D. Zoster in normal children after varicella vaccine. J Infect Dis 1989; 159:1000-1; PMID:2540244
   PubMed Web of Science ®Google Scholar
• Meurice F, De Bouver JL, Vandevoorde D, Woods S, Bogaerts H. Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children. J Infect Dis 1996; 174 Suppl 3:S324-9; PMID:8896540
   PubMedGoogle Scholar
• Varis T, Vesikari T. Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J Infect Dis 1996; 174 Suppl 3:S330-4; PMID:8896541
   PubMedGoogle Scholar
• Ozaki T. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program. Vaccine 2013; 31:6155-60; PMID:24183712
   PubMed Web of Science ®Google Scholar
• Silber JL, Chan IS, Wang WW, Matthews H, Kuter BJ. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age. Pediatr Infect Dis J 2007; 26:572-6; PMID:17596796
   PubMed Web of Science ®Google Scholar
• Arvin AM. Humoral and cellular immunity to varicella-zoster virus: an overview. J Infect Dis 2008; 197 Suppl 2:S58-60; PMID:18419410
   PubMed Web of Science ®Google Scholar
• Zerboni L, Nader S, Aoki K, Arvin AM. Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine. J Infect Dis 1998; 177:1701-4; PMID:9607852
   PubMed Web of Science ®Google Scholar
• Watson B, Gupta R, Randall T, Starr S. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. J Infect Dis 1994; 169:197-9; PMID:8277182
   PubMed Web of Science ®Google Scholar
• Breuer J, Schmid DS, Gershon AA. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella. J Infect Dis 2008; 197 Suppl 2:S147-51; PMID:18419389
   PubMed Web of Science ®Google Scholar
• Williams V, Gershon A, Brunell PA. Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. J Infect Dis 1974; 130:669-72; PMID:4372275
   PubMed Web of Science ®Google Scholar
• Declaration of Helsinki. Available from: http://www.who.int/bulletin/archives/79(4)373.pdf. Accessed March 11 2014
   Google Scholar